Duncan Williams Asset Management’s AnaptysBio ANAB Stock Holding History

Duncan Williams Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$440K	Hold	6,525	–	–	0.1%	111
2026 Q1	$362K	Hold	6,525	–	–	0.1%	112
2025 Q4	$316K	Buy	+6,525	New	+$254K	0.08%	130
2024 Q4	–	Sell	-8,425	Closed	-$282K	–	147
2024 Q3	$282K	Buy	+8,425	New	+$288K	0.16%	103

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Duncan Williams Asset Management's ANAB Position: Q2 2026 in Review

Duncan Williams Asset Management held its AnaptysBio (ANAB) position steady in Q2 2026 at 6,525 shares worth $440K. The position accounts for 0.1% of the portfolio, ranked #111.

Duncan Williams Asset Management first reported a position in ANAB in Q3 2024 and has held it in 4 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Duncan Williams Asset Management held 6,525 shares of AnaptysBio worth $440K as of Q2 2026.
Duncan Williams Asset Management left its AnaptysBio share count unchanged in Q2 2026.
AnaptysBio made up 0.1% of Duncan Williams Asset Management's portfolio in Q2 2026, its #111 holding.
Duncan Williams Asset Management first reported a position in AnaptysBio in Q3 2024 and has held it in 4 quarters since.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Duncan Williams Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.